Co-Diagnostics, Inc. Common Stock Capital Reinvestment Ratio
Co-Diagnostics, Inc. Common Stock capital reinvestment ratio. Co-Diagnostics, Inc. Common Stock (CODX) has a Capital Reinvestment Ratio of 0.21x as of September 2022, meaning it reinvests 0% of its operating cash flow ($1.12 Million) in capital expenditures ($230.05K). Check Co-Diagnostics, Inc. Common Stock (CODX) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Co-Diagnostics, Inc. Common Stock (2020–2022)
Capital reinvestment ratio of Co-Diagnostics, Inc. Common Stock from 2020 to 2022. This chart tracks Co-Diagnostics, Inc. Common Stock's Capital Reinvestment Ratio across 3 annual periods. Also explore Co-Diagnostics, Inc. Common Stock (CODX) equity growth momentum to track the company's year-over-year net asset growth rate.
Co-Diagnostics, Inc. Common Stock Capital Reinvestment Ratio by Year (2020–2022)
Co-Diagnostics, Inc. Common Stock capital reinvestment ratio by year from 2020 to 2022. For the full cash flow conversion analysis, see Co-Diagnostics, Inc. Common Stock operating cash flow efficiency.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.22x | $6.57 Million | $1.43 Million | ▲ +1233.6% |
| 2021 | 0.02x | $41.08 Million | $669.46K | ▼ -40.7% |
| 2020 | 0.03x | $28.17 Million | $774.40K | — |